Whitwell Jennifer L, Kantarci Kejal, Weigand Stephen D, Lundt Emily S, Gunter Jeffrey L, Duffy Joseph R, Strand Edythe A, Machulda Mary M, Spychalla Anthony J, Drubach Daniel A, Petersen Ronald C, Lowe Val J, Jack Clifford R, Josephs Keith A
Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Department of Health Sciences Research (Biostatistics), Mayo Clinic, Rochester, MN, USA.
J Alzheimers Dis. 2015;45(4):1109-17. doi: 10.3233/JAD-142628.
Microbleeds in the brain have been shown to occur in Alzheimer's disease (AD), affecting approximately a third of subjects that present with typical dementia of the Alzheimer's type (DAT). However, little is known about the frequency or distribution of microbleeds in subjects with AD that present with atypical clinical presentations.
To determine whether the frequency and regional distribution of microbleeds in atypical AD differs from that observed in subjects with DAT, and to determine whether microbleeds in atypical AD are associated with age, demographics, or cognitive impairment.
Fifty-five subjects with amyloid-β deposition on Pittsburgh compound B (PiB) PET who presented with predominant language (n = 37) or visuospatial/perceptual (n = 18) deficits underwent T2*weighted MRI. These subjects were compared to 41 PiB-positive subjects with DAT. Microbleeds were identified and assigned a lobar location.
The proportion of subjects with microbleeds did not differ between atypical AD (42%) and DAT (32%). However, atypical AD had larger numbers of microbleeds than DAT. In addition, the topographic distribution of microbleeds differed between atypical AD and DAT, with atypical AD showing the highest density of microbleeds in the frontal lobes. Among atypical AD, number of microbleeds was associated with age, but not gender or cognition. Microbleeds were more common in subjects with language (51%) versus visuospatial/perceptual deficits (22%).
Microbleeds are relatively common in both DAT and atypical AD, although atypical AD subjects appear to be at particular risk for developing large numbers of microbleeds and for developing microbleeds in the frontal lobe.
脑微出血已被证实在阿尔茨海默病(AD)中出现,约三分之一呈现典型阿尔茨海默型痴呆(DAT)的患者会出现脑微出血。然而,对于出现非典型临床表现的AD患者,脑微出血的频率或分布情况却知之甚少。
确定非典型AD中脑微出血的频率和区域分布是否与DAT患者不同,并确定非典型AD中的脑微出血是否与年龄、人口统计学特征或认知障碍相关。
55例在匹兹堡化合物B(PiB)PET上有淀粉样β蛋白沉积且以语言障碍为主(n = 37)或视觉空间/感知障碍为主(n = 18)的患者接受了T2*加权MRI检查。这些患者与41例PiB阳性的DAT患者进行比较。识别脑微出血并确定其叶位置。
非典型AD患者(42%)和DAT患者(32%)中出现脑微出血的比例无差异。然而,非典型AD患者的脑微出血数量多于DAT患者。此外,非典型AD和DAT患者脑微出血的地形分布不同,非典型AD患者额叶的脑微出血密度最高。在非典型AD患者中,脑微出血数量与年龄相关,与性别或认知无关。语言障碍患者(51%)比视觉空间/感知障碍患者(22%)更容易出现脑微出血。
脑微出血在DAT和非典型AD中都相对常见,尽管非典型AD患者似乎特别容易出现大量脑微出血和额叶脑微出血。